These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30846792)

  • 1. Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria.
    Ravaioli M; Odaldi F; Cucchetti A; Trevisani F; Piscaglia F; De Pace V; Bertuzzo VR; Neri F; Golfieri R; Cappelli A; D'Errico A; Cescon M; Del Gaudio M; Fallani G; Siniscalchi A; Morelli MC; Ciccarese F; Di Marco M; Farinati F; Giannini EG; Pinna AD
    Sci Rep; 2019 Mar; 9(1):3781. PubMed ID: 30846792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
    Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
    World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
    Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG
    Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of loco-regional therapy for down-staging of hepatocellular carcinoma prior to liver transplantation.
    Shi XJ; Jin X; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
    Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):143-50. PubMed ID: 21459720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy.
    Lei JY; Yan LN; Wang WT
    World J Gastroenterol; 2013 Jul; 19(27):4400-8. PubMed ID: 23885153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy.
    Cucchetti A; Cescon M; Bigonzi E; Piscaglia F; Golfieri R; Ercolani G; Cristina Morelli M; Ravaioli M; Daniele Pinna A
    Liver Transpl; 2011 Nov; 17(11):1344-54. PubMed ID: 21837731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions.
    Schmitt TM; Kumer SC; Shah N; Argo CK; Northup PG
    Ann Hepatol; 2010; 9(4):390-6. PubMed ID: 21057157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies.
    El-Gazzaz G; Sourianarayanane A; Menon KV; Sanabria J; Hashimoto K; Quintini C; Kelly D; Eghtesad B; Miller C; Fung J; Aucejo F
    Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):34-41. PubMed ID: 23392796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria.
    Ravaioli M; Grazi GL; Piscaglia F; Trevisani F; Cescon M; Ercolani G; Vivarelli M; Golfieri R; D'Errico Grigioni A; Panzini I; Morelli C; Bernardi M; Bolondi L; Pinna AD
    Am J Transplant; 2008 Dec; 8(12):2547-57. PubMed ID: 19032223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis.
    Sourianarayanane A; El-Gazzaz G; Sanabria JR; Menon KV; Quintini C; Hashimoto K; Kelly D; Eghtesad B; Miller C; Fung J; Aucejo F
    HPB (Oxford); 2012 May; 14(5):325-32. PubMed ID: 22487070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
    Agopian VG; Harlander-Locke MP; Ruiz RM; Klintmalm GB; Senguttuvan S; Florman SS; Haydel B; Hoteit M; Levine MH; Lee DD; Taner CB; Verna EC; Halazun KJ; Abdelmessih R; Tevar AD; Humar A; Aucejo F; Chapman WC; Vachharajani N; Nguyen MH; Melcher ML; Nydam TL; Mobley C; Ghobrial RM; Amundsen B; Markmann JF; Langnas AN; Carney CA; Berumen J; Hemming AW; Sudan DL; Hong JC; Kim J; Zimmerman MA; Rana A; Kueht ML; Jones CM; Fishbein TM; Busuttil RW
    Ann Surg; 2017 Sep; 266(3):525-535. PubMed ID: 28654545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after Liver Transplant: Influence of Progression of Disease and of Restoration of the "Milan" Criteria in Patients with Hepato-cellular Carcinoma undergoing Down-staging Procedures.
    Giacomoni A; Di Sandro S; Donadon M; Lauterio A; Belli L; Mangoni I; Mihaylov P; Concone G; De Carlis L
    Hepatogastroenterology; 2015 Jun; 62(140):955-61. PubMed ID: 26902036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation.
    Guerrini GP; Pinelli D; Di Benedetto F; Marini E; Corno V; Guizzetti M; Aluffi A; Zambelli M; Fagiuoli S; Lucà MG; Lucianetti A; Colledan M
    Surg Oncol; 2016 Dec; 25(4):419-428. PubMed ID: 26403621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
    Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
    World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.
    Kornberg A; Küpper B; Tannapfel A; Büchler P; Krause B; Witt U; Gottschild D; Friess H
    Liver Transpl; 2012 Jan; 18(1):53-61. PubMed ID: 21850692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up Imaging After Liver Transplantation Should Take Into Consideration Primary Hepatocellular Carcinoma Characteristics.
    Dioguardi Burgio M; Ronot M; Fuks D; Dondero F; Cauchy F; Gaujoux S; Dokmak S; Paradis V; Durand F; Belghiti J; Vilgrain V
    Transplantation; 2015 Aug; 99(8):1613-8. PubMed ID: 25710611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study.
    Kim JH; Sinn DH; Gwak GY; Choi GS; Kim JM; Kwon CHD; Joh JW; Kim KY; Kim K; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Medicine (Baltimore); 2016 Aug; 95(35):e4735. PubMed ID: 27583916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.
    Sapisochin G; Castells L; Dopazo C; Bilbao I; Minguez B; Lázaro JL; Allende H; Balsells J; Caralt M; Charco R
    Ann Surg Oncol; 2013 Apr; 20(4):1194-202. PubMed ID: 22965574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions.
    Chapman WC; Garcia-Aroz S; Vachharajani N; Fowler K; Saad N; Lin Y; Wellen J; Tan B; Khan AS; Doyle MB
    J Am Coll Surg; 2017 Apr; 224(4):610-621. PubMed ID: 28069527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation.
    Kim PT; Onaca N; Chinnakotla S; Davis GL; Jennings LW; McKenna GJ; Ruiz RM; Levy MF; Goldstein R; Klintmalm GB
    Clin Transplant; 2013; 27(2):311-8. PubMed ID: 23351129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.